![Colin Michael Bond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Michael Bond
Directeur/Membre du Conseil chez
AGOMAB THERAPEUTICS NV
Fortune : 95 400 $ au 30/06/2026
Profil
Actuellement, Colin Bond est président non exécutif de European ScreeningPort GmbH et directeur financier de Vifor Pharma AG, directeur financier de Vifor Pharma Management AG (une filiale de Vifor Pharma AG). Il est également membre du conseil d'administration de Siegfried Holding AG, de Vifor Fresenius Medical Care Renal Pharma Ltd. et de BioPharma Credit PLC et membre de la Royal Pharmaceutical Society of Great Britain. Colin Bond a précédemment occupé le poste de directeur financier d'Evotec SE, de directeur financier de Great Lakes Chemical Corp, de directeur financier de Novelis AG, de directeur financier de Novelis Europe Holdings Ltd, de directeur financier de Jet Aviation Management AG, de directeur financier d'Ecolab (Schweiz) GmbH, d'auditeur de PricewaterhouseCoopers LLP, d'auditeur d'Arthur Andersen AG et d'auditeur de Procter & Gamble AG. Colin Bond a obtenu un MBA de la London Business School et un diplôme de premier cycle de l'université d'Aston.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOPHARMA CREDIT PLC USD 0,01 % | 31/12/2025 | 100 000 ( 0,01 % ) | 95 400 $ | 30/06/2026 |
| 31/12/2025 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 18/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Dernières actualités sur Colin Michael Bond
Postes actifs de Colin Michael Bond
| Sociétés | Poste | Début |
|---|---|---|
| BIOPHARMA CREDIT PLC | Directeur/Membre du Conseil | 01/11/2016 |
| FORMYCON AG | Directeur/Membre du Conseil | 01/10/2024 |
| OXFORD BIOMEDICA PLC | Directeur/Membre du Conseil | 01/01/2025 |
| FARON PHARMACEUTICALS OY | Directeur/Membre du Conseil | 21/03/2025 |
| AGOMAB THERAPEUTICS NV | Directeur/Membre du Conseil | 01/11/2024 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Directeur/Membre du Conseil | 23/06/2025 |
Medichem SA
 Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients | Directeur/Membre du Conseil | 01/01/2025 |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
European ScreeningPort GmbH | Président | 01/01/2013 |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Colin Michael Bond
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Colin Michael Bond
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
31
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 31 |
|---|---|
Great Lakes Chemical Corp.
 Great Lakes Chemical Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, production, sales and distribution of specialty chemicals | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Novelis AG
 Novelis AG AluminumNon-Energy Minerals Produces flat-rolled aluminum products and recycles aluminum | Non-Energy Minerals |
Novelis Europe Holdings Ltd.
 Novelis Europe Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company. | Miscellaneous |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Siegfried Holding AG
 Siegfried Holding AG Pharmaceuticals: MajorHealth Technology Develops and manufactures active pharmaceutical ingredients, dosage forms & biopharmaceutical substances | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services Provides expertise and support to its member pharmacists | Commercial Services |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
DeveloGen AG
 DeveloGen AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic drugs | Health Technology |
Siegfried AG
 Siegfried AG Chemicals: AgriculturalProcess Industries Manufactures chemical products | Process Industries |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Jet Aviation Management AG
 Jet Aviation Management AG Other TransportationTransportation Provides aircraft maintenance, management, sales and charter services | Transportation |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arthur Andersen AG
 Arthur Andersen AG Miscellaneous Commercial ServicesCommercial Services Part of Arthur Andersen LLP, Arthur Andersen AG is a company based in Geneva, Switzerland. | Commercial Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Procter & Gamble AG
 Procter & Gamble AG Food DistributorsDistribution Services Engages in marketing of consumer goods | Distribution Services |
Medichem SA
Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients | Health Technology |
Jet Aviation AG
 Jet Aviation AG Other TransportationTransportation Provides aircraft maintenance services | Transportation |
European ScreeningPort GmbH | |
Formycon AG
 Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
Ecolab (Schweiz) GmbH | |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
BioPharma Credit PLC
 BioPharma Credit PLC Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Sandoz Group AG
 Sandoz Group AG Pharmaceuticals: MajorHealth Technology Manufactures medicines and biosimilars | Health Technology |
